April 11, 2017 / 3:57 PM / in 7 months

BRIEF-Collplant Holdings reports positive results from post-marketing surveillance of Vergenix FG

April 11 (Reuters) - Collplant Holdings Ltd:

* Announce positive results from post-marketing surveillance of company’s advanced wound care product, Vergenix FG

* As part of surveillance, co monitored 10 patients following a single treatment with Vergenix FG in hospitals in Italy, Switzerland

* Study showed 5 weeks post treatment, patients displayed average wound closure rate of 80%, with no observed safety/ tolerability issues Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below